Federal award
DMS PHARMACEUTICAL GROUP INC
9249
Contract
Obligated and Ceiling
- Obligated (net)
- $52,876.80
- Ceiling (potential value, not spending)
- $52,876.80
- Current value
- $52,876.80
- Gross positive obligations
- $991,440.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
- Owner company
- DMS Pharmaceutical GroupBasis direct: the recipient is the company's own reviewed UEI.
- Reported parent
- DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
- Awarding agency
- Department of Defense · sub-agency 97AS · office SPE2DP
- Funding agency
- Department of Defense · sub-agency 97AS
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- 9249
- Parent vehicle (IDV PIID)
- SPE2DX15D9383
- Award type code
- C
- Actions
- 2 · Sep 29, 2016 to Feb 9, 2017
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History2
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 9, 2017 | FY2017 | 1 | M | −$938,563.20 | |
| Sep 29, 2016 | FY2016 | 0 | — | $991,440.00 |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.